Home - Products - Cell Cycle/DNA Damage - GPR - 1-methoxycyclopropanecarboxylic acid

1-methoxycyclopropanecarboxylic acid

CAS No. 100683-08-7

1-methoxycyclopropanecarboxylic acid( —— )

Catalog No. M28687 CAS No. 100683-08-7

1-methoxycyclopropanecarboxylic acid is an agonist of free fatty acid receptor 3 (FFAR3, human).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 29 Get Quote
5MG 45 Get Quote
10MG 68 Get Quote
25MG 115 Get Quote
50MG 173 Get Quote
100MG 258 Get Quote
200MG 388 Get Quote
500MG 642 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    1-methoxycyclopropanecarboxylic acid
  • Note
    Research use only, not for human use.
  • Brief Description
    1-methoxycyclopropanecarboxylic acid is an agonist of free fatty acid receptor 3 (FFAR3, human).
  • Description
    1-methoxycyclopropanecarboxylic acid is an agonist of free fatty acid receptor 3 (FFAR3, human).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    GPR
  • Recptor
    Antifungal
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    100683-08-7
  • Formula Weight
    116.116
  • Molecular Formula
    C5H8O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    COC1(CC1)C(O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Wang, S.Y., Sun, T., and Faust, M.Translocation of paclobutrazol, a gibberellin biosynthesis inhibitor, in apple seedlingsPlant Physiology82(1)11-14(1986)
molnova catalog
related products
  • AMG-009

    AMG-009 is a selective and potent dual antagonist of CRTH2 and DP, with an IC50 value of 3 nM for CRTH2 and 12 nM for DP receptors.

  • GW 9508

    GW9508 is a potent and selective agonist for FFA1 (GPR40) with pEC50 of 7.32.

  • ML 145

    ML 145 is a selective and potent antagonist of human GPR35, with no significant activity against GPR35 in any of its immediate rodent homologs.